The shortest delivery time is 3 weeks, and it is possible to analyze gene expression and explore splicing variants. This book presents insights and comments unique to contract manufacturers.
We offer a "contract service for RNA-seq analysis." Our service allows for genome-wide expression analysis unique to NGS, enabling comprehensive detection of genes ranging from low to high expression levels. We can also explore novel transcripts and splicing variants. Additionally, we have a plan with the shortest delivery time of "3 weeks." (This applies when the analysis conditions are 50+25bp paired-end or 75bp paired-end.) We can also provide proposals tailored to your needs. 【Features】 ■ Active in various institutions, including companies, research institutions, and universities, regardless of industry or academia ■ Analysis is possible for any organism that possesses RNA, whether eukaryotic or prokaryotic ■ By combining with ChIP-seq, it is possible to confirm the activity of transcription factors from expression levels *We are currently offering materials that clearly introduce the principles and benefits of RNA-seq! For more details, please check the PDF download. Feel free to contact us with any inquiries.
Inquire About This Product
basic information
【Document Contents (Excerpt)】 - What is RNA-seq? - What is the delivery time? - How much does it cost when outsourced? - What are the advantages compared to microarrays? - What is the difference from single-cell RNA-seq? - About the sequence read length - Does the analysis cost vary by species? *For more details, please refer to the document. Feel free to contact us with any inquiries.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the materials. Feel free to contact us as well.
catalog（3）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.
